DONALD FOSTER: Open Payments
NPI 1811363286 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 27 payments from 7 companies in 2025. Trend: 2023 $2,008 · 2024 $2,052 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $382 |
| Boston Scientific Corporation | 3 | $179 |
| Edwards Lifesciences Corporation | 1 | $173 |
| Novartis Pharmaceuticals Corporation | 4 | $132 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Amgen Inc. | 2 | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
Products named: CARDIOMEMS, SAPIEN 3 Ultra RESILIA, WATCHMAN Access System, LEQVIO, MERLIN@HOME, VERQUVO, ASSURITY, REPATHA.
Industry payments across TX — which companies pay providers there.
